A01K 2267/025
Animal producing cells or organs for transplantation
A01K2267/025 (Animal producing cells or organs for transplantation) appears on 166 US grants and 291 published applications in this corpus.
Search patents in A01K- Granted patents
- 166
- Published applications
- 291
- Assignees
- 159
- Inventors
- 470
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 10 | 0 |
| 2001 | 7 | 2 |
| 2002 | 5 | 25 |
| 2003 | 8 | 19 |
| 2004 | 5 | 14 |
| 2005 | 5 | 13 |
| 2006 | 8 | 19 |
| 2007 | 5 | 8 |
| 2008 | 5 | 9 |
| 2009 | 7 | 7 |
| 2010 | 4 | 10 |
| 2011 | 3 | 6 |
| 2012 | 4 | 6 |
| 2013 | 4 | 5 |
| 2014 | 1 | 9 |
| 2015 | 2 | 9 |
| 2016 | 7 | 6 |
| 2017 | 3 | 10 |
| 2018 | 5 | 15 |
| 2019 | 7 | 19 |
| 2020 | 6 | 14 |
| 2021 | 16 | 14 |
| 2022 | 5 | 18 |
| 2023 | 5 | 9 |
| 2024 | 6 | 6 |
| 2025 | 4 | 9 |
| 2026 | 4 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Multi-transgenic pig for Xenotransplantation25 Aug 2026US 12,714,077 B2Revivicor, Inc.
- Multitransgenic pigs comprising ten genetic modifications for xenotransplantation9 Jun 2026US 12,648,548 B2Revivicor, Inc.
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance26 May 2026US 12,637,690 B2eGenesis, Inc.
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance19 May 2026US 12,630,838 B2eGenesis, Inc.
- Genetically modified cells, tissues, and organs for treating disease11 Nov 2025US 12,465,029 B2Regents of the University of Minnesota
- Non-human animal, kit, and method for producing replacement organ24 Sep 2026US 2026/0283124 A1The Jikei University
- Compositions and methods for generating porcine ovarian tumor model6 Aug 2026US 2026/0223823 A1Georgia Tech Research Corporation
- Ethical tissues for transplantation30 Jul 2026US 2026/0218123 A1
- Multitransgenic pigs comprising ten genetic modifications for xenotransplantation18 Jun 2026US 2026/0165304 A1Revivicor, Inc.
- Skin tissue28 May 2026US 2026/0144238 A1The University of Tokyo
Most cited
By later US patents
- Transgenic non-human animals for producing heterologous antibodies182US 6,300,129 B1GenPharm International, Inc. · 2001
- Human CTLA-4 antibodies and their uses142US 7,605,238 B2Medarex, Inc. · 2009
- Homologous recombination for universal donor cells and chimeric mammalian hosts84US 5,574,205 ACell Genesys, Inc. · 1996
- Human CTLA-4 antibodies and their uses67US 8,017,114 B2Medarex, Inc. · 2011
- Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor65US 6,166,288 ANextran Inc. · 2000